Date: Wednesday, March 4, 2026 Time: 12:00–1:30 PM ET Duration: 90 minutes Session Type: Pre-Recorded Background Content + Expert-Led AMA & Applied LearningFormat: Live Virtual (Zoom)
Link: https://us06web.zoom.us/j/87442724043?pwd=XryBk7Ee0x5wfMIdZMPAiVyxPmclI7.1
Presented by:
Session Overview
Access to capital remains one of the most significant challenges facing early-stage foodtech and novel ingredient companies, particularly those navigating R&D-intensive development, long commercialization timelines, and constrained cash flow. Session 8 is designed to equip founders with practical tools and strategies to fund innovation responsibly while managing financial risk.
This session focuses on real-world financing considerations for technology-driven food businesses, with a particular emphasis on SR&ED tax incentives, SR&ED financing, and early-stage capital planning. Rather than theoretical finance, the session emphasizes founder readiness, informed decision-making, and financial resilience during periods of uncertainty and high burn.
What You Will Learn
In this session, founders will:
- Understand how the SR&ED program works and how it applies to foodtech and technology-focused ventures
- Learn how SR&ED tax credits can be leveraged through SR&ED financing to support cash flow and ongoing R&D
- Identify common mistakes first-time SR&ED claimants make and how to avoid them
- Explore early-stage financing strategies, including non-dilutive capital, debt considerations, and capital planning
- Strengthen their ability to manage financial risk, including runway planning and downside scenario preparedness
--
Easly is Canada’s market leader in SR&ED financing, providing companies with R&D early access to their expected SR&ED refunds.
From coast to coast, Easly assists businesses of all sizes, innovation stage, and industry verticals to scale their innovation programs through smart capital solutions. They have deployed over $320m of funds to Canadian innovation businesses.
Easly Advances are available as one-off capital injections, or can be used strategically throughout the year. Find out how innovation businesses across Canada are using non-dilutive SR&ED financing to accelerate growth, attract other sources of funding and smooth cash flow at https://fundeasly.com/
